The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Glanzmann Thrombasthenia Therapeutic Drug Market Research Report 2025
Synopsis
The global Glanzmann Thrombasthenia Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Glanzmann Thrombasthenia Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glanzmann Thrombasthenia Therapeutic Drug.
Report Scope
The Glanzmann Thrombasthenia Therapeutic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glanzmann Thrombasthenia Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glanzmann Thrombasthenia Therapeutic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer
Segment by Type
Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glanzmann Thrombasthenia Therapeutic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Glanzmann Thrombasthenia Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Glanzmann Thrombasthenia Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glanzmann Thrombasthenia Therapeutic Drug.
Report Scope
The Glanzmann Thrombasthenia Therapeutic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glanzmann Thrombasthenia Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glanzmann Thrombasthenia Therapeutic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer
Segment by Type
Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glanzmann Thrombasthenia Therapeutic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Platelet Transfusion
1.2.3 Recombinant Activated Factor VII
1.2.4 Antifibrinolytics
1.2.5 Fibrin Sealants
1.2.6 Thrombin
1.2.7 Desmopressin
1.3 Market by Application
1.3.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Perspective (2019-2030)
2.2 Glanzmann Thrombasthenia Therapeutic Drug Growth Trends by Region
2.2.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Region (2019-2024)
2.2.3 Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Region (2025-2030)
2.3 Glanzmann Thrombasthenia Therapeutic Drug Market Dynamics
2.3.1 Glanzmann Thrombasthenia Therapeutic Drug Industry Trends
2.3.2 Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
2.3.3 Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
2.3.4 Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue
3.1.1 Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Revenue (2019-2024)
3.1.2 Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Players (2019-2024)
3.2 Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glanzmann Thrombasthenia Therapeutic Drug Revenue
3.4 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio
3.4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2023
3.5 Glanzmann Thrombasthenia Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Type
4.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Type (2019-2024)
4.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2025-2030)
5 Glanzmann Thrombasthenia Therapeutic Drug Breakdown Data by Application
5.1 Global Glanzmann Thrombasthenia Therapeutic Drug Historic Market Size by Application (2019-2024)
5.2 Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2019-2030)
6.2 North America Glanzmann Thrombasthenia Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024)
6.4 North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size (2019-2030)
7.2 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024)
7.4 Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size (2019-2030)
8.2 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size (2019-2030)
9.2 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024)
9.4 Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size (2019-2030)
10.2 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.1.4 Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.1.5 Novo Nordisk Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Detail
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Shire (Takeda)
11.3.1 Shire (Takeda) Company Detail
11.3.2 Shire (Takeda) Business Overview
11.3.3 Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.3.4 Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.3.5 Shire (Takeda) Recent Development
11.4 Biogen
11.4.1 Biogen Company Detail
11.4.2 Biogen Business Overview
11.4.3 Biogen Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.4.4 Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.4.5 Biogen Recent Development
11.5 Bioverativ (Sanofi)
11.5.1 Bioverativ (Sanofi) Company Detail
11.5.2 Bioverativ (Sanofi) Business Overview
11.5.3 Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.5.4 Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.5.5 Bioverativ (Sanofi) Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.6.4 Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 CSL Behring
11.7.1 CSL Behring Company Detail
11.7.2 CSL Behring Business Overview
11.7.3 CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.7.4 CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.7.5 CSL Behring Recent Development
11.8 Grifols
11.8.1 Grifols Company Detail
11.8.2 Grifols Business Overview
11.8.3 Grifols Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.8.4 Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.8.5 Grifols Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.9.4 Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Glanzmann Thrombasthenia Therapeutic Drug Introduction
11.10.4 Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Platelet Transfusion
Table 3. Key Players of Recombinant Activated Factor VII
Table 4. Key Players of Antifibrinolytics
Table 5. Key Players of Fibrin Sealants
Table 6. Key Players of Thrombin
Table 7. Key Players of Desmopressin
Table 8. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2019-2024)
Table 12. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2025-2030)
Table 14. Glanzmann Thrombasthenia Therapeutic Drug Market Trends
Table 15. Glanzmann Thrombasthenia Therapeutic Drug Market Drivers
Table 16. Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
Table 17. Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
Table 18. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players (2019-2024)
Table 20. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2023)
Table 21. Ranking of Global Top Glanzmann Thrombasthenia Therapeutic Drug Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Glanzmann Thrombasthenia Therapeutic Drug Product Solution and Service
Table 25. Date of Enter into Glanzmann Thrombasthenia Therapeutic Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2019-2024)
Table 29. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Type (2025-2030)
Table 31. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Application (2019-2024)
Table 33. Global Glanzmann Thrombasthenia Therapeutic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Application (2025-2030)
Table 35. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 50. Novo Nordisk Company Detail
Table 51. Novo Nordisk Business Overview
Table 52. Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Product
Table 53. Novo Nordisk Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 54. Novo Nordisk Recent Development
Table 55. Alnylam Pharmaceuticals Company Detail
Table 56. Alnylam Pharmaceuticals Business Overview
Table 57. Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Product
Table 58. Alnylam Pharmaceuticals Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 59. Alnylam Pharmaceuticals Recent Development
Table 60. Shire (Takeda) Company Detail
Table 61. Shire (Takeda) Business Overview
Table 62. Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Product
Table 63. Shire (Takeda) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 64. Shire (Takeda) Recent Development
Table 65. Biogen Company Detail
Table 66. Biogen Business Overview
Table 67. Biogen Glanzmann Thrombasthenia Therapeutic Drug Product
Table 68. Biogen Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 69. Biogen Recent Development
Table 70. Bioverativ (Sanofi) Company Detail
Table 71. Bioverativ (Sanofi) Business Overview
Table 72. Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Product
Table 73. Bioverativ (Sanofi) Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 74. Bioverativ (Sanofi) Recent Development
Table 75. Bayer Company Detail
Table 76. Bayer Business Overview
Table 77. Bayer Glanzmann Thrombasthenia Therapeutic Drug Product
Table 78. Bayer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 79. Bayer Recent Development
Table 80. CSL Behring Company Detail
Table 81. CSL Behring Business Overview
Table 82. CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Product
Table 83. CSL Behring Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 84. CSL Behring Recent Development
Table 85. Grifols Company Detail
Table 86. Grifols Business Overview
Table 87. Grifols Glanzmann Thrombasthenia Therapeutic Drug Product
Table 88. Grifols Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 89. Grifols Recent Development
Table 90. Bristol-Myers Squibb Company Detail
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Product
Table 93. Bristol-Myers Squibb Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Pfizer Company Detail
Table 96. Pfizer Business Overview
Table 97. Pfizer Glanzmann Thrombasthenia Therapeutic Drug Product
Table 98. Pfizer Revenue in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Type: 2023 VS 2030
Figure 3. Platelet Transfusion Features
Figure 4. Recombinant Activated Factor VII Features
Figure 5. Antifibrinolytics Features
Figure 6. Fibrin Sealants Features
Figure 7. Thrombin Features
Figure 8. Desmopressin Features
Figure 9. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Application: 2023 VS 2030
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Glanzmann Thrombasthenia Therapeutic Drug Report Years Considered
Figure 15. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Glanzmann Thrombasthenia Therapeutic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region: 2023 VS 2030
Figure 18. Global Glanzmann Thrombasthenia Therapeutic Drug Market Share by Players in 2023
Figure 19. Global Top Glanzmann Thrombasthenia Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2023
Figure 21. North America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2019-2030)
Figure 23. United States Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2019-2030)
Figure 27. Germany Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Glanzmann Thrombasthenia Therapeutic Drug Market Share by Region (2019-2030)
Figure 35. China Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2019-2030)
Figure 43. Mexico Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Market Share by Country (2019-2030)
Figure 47. Turkey Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Glanzmann Thrombasthenia Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Novo Nordisk Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 50. Alnylam Pharmaceuticals Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 51. Shire (Takeda) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 52. Biogen Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 53. Bioverativ (Sanofi) Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 54. Bayer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 55. CSL Behring Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 56. Grifols Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 58. Pfizer Revenue Growth Rate in Glanzmann Thrombasthenia Therapeutic Drug Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
